Table 2 Baseline haemostatic markers in the total population and stratified into groups according to angiographically verified CAD or not
From: Pro-coagulant activity during exercise testing in patients with coronary artery disease
Overall (n = 106) | CAD (n = 70) | No CAD (n = 36) | P-value | |
|---|---|---|---|---|
Hb (g/dL) | 14.6 (13.6, 15.1) | 14.7 (13.6, 15.2) | 14.3 (13.4, 15.1) | 0.481 |
Hematocrit (units) | 0.43 (0.40, 0.44) | 0.43 (0.40, 0.44) | 0.42 (0.40, 0.44) | 0.711 |
Leucocytes (x 10e9) | 6.60 (5.80, 7.90) | 6.4 (5.8, 7.8) | 6.8 (5.7, 8.3) | 0.502 |
Platelets (x 10e9) | 234 (201, 273) | 222 (192, 261) | 251 (232, 294) | 0.003 |
Lactate (mmol/L) | 1.40 (1.20, 2.00) | 1.4 (1.2, 2.0) | 1.4 (1.0, 2.0) | 0.759 |
LT (min) | 3.09 (2.68, 3.67) | 3.0 (2.7, 3.3) | 3.2 (2.9, 3.7) | 0.301 |
ETP (nM*min) | 1406 (1283, 1554) | 1397 (1281, 1546) | 1420 (1279, 1581) | 0.667 |
PeakH (nM) | 271.2 (243.3, 307.8) | 265 (246, 308) | 280 (233, 321) | 0.662 |
ttPeak (min) | 5.68 (5.17, 6.36) | 289 (247, 329) | 286 (253, 324) | 0.346 |
Velo (nM/min−1) | 103 (87, 132) | 103 (88, 131) | 110 (82, 135) | 0.949 |
F1 + 2 (pmol/L) | 280 (216, 341) | 282 (216, 338) | 275 (214, 359) | 0.679 |
D-dimer (ng/ml) | 348 (210, 581) | 381 (221, 583) | 296 (196, 578) | 0.412 |
Free TFPI (ng/ml) | 16 (13, 20) | 15 (13, 19) | 16 (12, 20) | 0.741 |
Total TFPI (ng/ml) | 71 (60, 81) | 67 (58, 79) | 77 (64, 84) | 0.027 |